Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
Zoe Waibler, Linda Y. Sender, Camilla Merten et al. · 2008
Read Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies by Zoe Waibler, Linda Y. Sender, Camilla Merten et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001708.txt.
Description
Zoe Waibler, Linda Y. Sender, Camilla Merten, and their co-authors profiled powerful immune-activating antibodies in a 2008 PLOS ONE research article. Superagonistic CD28 antibodies switch T cells on without the usual co-signal from the T-cell receptor complex. In rodents they expand regulatory T cells and can treat autoimmune disease. In a human trial, though, such an antibody caused severe harm, making its signals a safety question.
The team mapped the signaling signatures and functional properties of anti-human CD28 superagonists. The full text gives the cell tests and which pathways fired. Knowing exactly what these antibodies do in human cells is a precondition for any safe return of the class. It is also a case study in how animal results can mislead.
Catalog record
| CREATOR | Zoe Waibler, Linda Y. Sender, Camilla Merten et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001708